Presentation is loading. Please wait.

Presentation is loading. Please wait.

Hypothalamic & Pituitary Hormones

Similar presentations


Presentation on theme: "Hypothalamic & Pituitary Hormones"— Presentation transcript:

1 Hypothalamic & Pituitary Hormones
Kaukab Azim, MBBS, PhD

2 Uses of Hypothalamic & Pituitary Hormones
Short stature due to hypopituitarism (Pituitary dwarfism) Acromegaly and gigantism Carcinoid syndrome, VIPoma, and ruptured esophageal varices Hyperprolactinemia Induction of labor Diabetes insipidus SIADH

3 Concepts in Endocrinology
Primary, secondary and tertiary endocrine disorders Feedback regulation Endocrine disorders: Deficiency, or Excess Mechanisms of action Uses of hormones /analogs: Diagnostic use Therapeutic use

4 Growth hormone releasing hormone (GHRH)
GHRH analog: Sermorelin Used rarely as a diagnostic test for GH responsiveness

5 IGF-1 as Peripheral effector
Growth Hormone Secretion of GH is stimulated by GHRH and inhibited by GIH (somatostatin) GH preparations for therapeutic use: Somatropin: Recombinant human GH Somatrem: Recombinant human GH IGF-1 as Peripheral effector

6 Molecular and Cellular Basis of GH Action

7 Growth hormone (Somatotropin)
Most of the actions of GH are mediated by IGF-1 (somatomedins) - the peptides produced in the liver and cartilage. The somatomedins stimulate skeletal growth, amino acid transport, protein synthesis, nucleic acid synthesis and cell proliferation. Gluconeogenesis

8 Therapeutic uses of GH Short stature due to Congenital/acquired GH deficiency (Pituitary Dwarfism) GH deficiency in adults Turner’s syndrome AIDS related muscle wasting

9 GH preparations: Adverse effects
In children Increased Intracranial tension Headache Papilledema Scoliosis Diabetes mellitus In adults Peripheral edema Arthritis Arthralgia Myalgia Carpal tunnel syndrome Diabetes mellitus

10 Growth hormone inhibiting hormone (Somatostatin)
Somatostatin analogs: Octreotide – S/C, daily Sandostatin-LAR - (Slow release preparation of octreotide) once every 4 weeks Administration of somatostatin analogs result in decrease in GH and IGF-1 levels

11 Somatostatin analogs: Therapeutic uses
Acromegaly To prevent gigantism Carcinoid syndrome VIPoma, gastrinoma Ruptured esophageal varices

12 Somatostatin analogs: Adverse drug reactions
GIT problems: abdominal cramps, diarrhea, malabsorption, steatorrhea Gall stones Vitamin B12 deficiency Cardiovascular problems: Sinus bradycardia, conduction disturbances

13 GH antagonist Pegvisomant Decreases IGF-1; GH remains high
Also effective in those who do not/stop responding to octreotide

14 Prolactin Secretion of prolactin is under the control of dopamine (prolactin inhibiting hormone) secreted by hypothalamus

15

16 Prolactin

17 Hyperprolactinemia Prolactin secreting pituitary adenoma
Drug induced hyperprolactinemia Antipsychotics Metochlopramide Drugs to manage hyperprolactinemia: Bromocriptine Cabergoline (ka-BER-goe-leen)

18 Oxytocin Actions meditated through IP3/DAG ↑ Ca+2 Therapeutic uses
To induce and augment labor after cervix has ripened To control post-partum hemorrhage To improve milk ejection – nasal oxytocin

19 Oxytocin : Adverse reactions
Cardiac arrhythmia, CNS stimulation, excessive uterine contractions, and hyponatremia. Contraindications: Fetal distress Abnormal fetal presentation Prematurity CPD (cephalo-pelvic disproportion)

20 Vasopressin (arginine-vasopressin)
Vasopressin has: Antidiuretic activity Vasopressor activity (Vasoconstriction) Decreased secretion/response to ADH causes Diabetes insipidus Excessive secretion of ADH causes: SIADH

21 Vasopressin receptors
V1 receptors: On vascular smooth muscles Pressor effect: meditated through IP3/DAG ↑Ca+2 V2 receptors Renal: On distal and collecting duct cells of nephron Antidiuretic effect: mediated through ↑cAMP Extrarenal: Release of coagulation factors VIIIc and Von willebrand factor

22 Therapeutic uses of vasopressin/analogs
Vasopressin (Pitressin) Therapeutic uses Advanced Cardiac life support Bleeding esophageal varices Desmopressin Long-acting synthetic analog of vasopressin Antidiuretic : vasopressor activity = 3000:1 Therapeutic uses: Neurogenic diabetes insipidus Von Willebrand disease and hemophillia Enuresis

23 SIADH Due to excessive secretion of ADH Drug induced SIADH:
Carbamazepine, vinca alkaloids, Chlorpropamide Drugs to manage SIADH Demeclocycline Conivaptan (vasopressin antagonist)

24 Questions…


Download ppt "Hypothalamic & Pituitary Hormones"

Similar presentations


Ads by Google